(Q43773475)

English

Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment

scientific article published in October 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 November 2017

Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment (English)

1 reference

Europe PubMed Central

26 November 2017

author name string

A Serrano

1

1 reference

Europe PubMed Central

26 November 2017

S Tanzarella

2

1 reference

Europe PubMed Central

26 November 2017

I Lionello

3

1 reference

Europe PubMed Central

26 November 2017

R Mendez

4

1 reference

Europe PubMed Central

26 November 2017

C Traversari

5

1 reference

Europe PubMed Central

26 November 2017

F Ruiz-Cabello

6

1 reference

Europe PubMed Central

26 November 2017

F Garrido

7

1 reference

Europe PubMed Central

26 November 2017

language of work or name

0 references

publication date

1 October 2001

1 reference

Europe PubMed Central

26 November 2017

International Journal of Cancer

1 reference

Europe PubMed Central

26 November 2017

94

1 reference

Europe PubMed Central

26 November 2017

243-251

1 reference

Europe PubMed Central

26 November 2017

2

1 reference

Europe PubMed Central

26 November 2017

Antigen recognition by class I-restricted T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Viral strategies of immune evasion

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Natural history of HLA expression during tumour development.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

A new beta 2 microglobulin mutation found in a melanoma tumor cell line

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Identification of human cancers deficient in antigen processing

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Dendritic cells acquire the MAGE-3 human tumor antigen from apoptotic cells and induce a class I-restricted T cell response

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Isolation of HLA locus-specific DNA probes from the 3'-untranslated region

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody 131.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

HLA-E is the only class I gene that escapes CpG methylation and is transcriptionally active in the trophoblast-derived human cell line JAR.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

The HLA crossroad in tumor immunology

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Immunoresistant metastatic tumor variants can re-express their tumor antigen after treatment with DNA methylation-inhibiting agents

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Multiple mechanisms underlie HLA dysregulation in cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

CG dinucleotide clusters in MHC genes and in 5' demethylated genes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

CpG islands and HTF islands in the HLA class I region: investigation of the methylation status of class I genes leads to precise physical mapping of the HLA-B and -C genes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

High frequency of altered HLA class I phenotypes in laryngeal carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Immune surveillance in colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Mutation in the beta 2m gene is not a frequent event in head and neck squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Tapping into tumours

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Molecular strategies to define HLA haplotype loss in microdissected tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

CpG methylation patterns in the 5' part of the nonclassical HLA-G gene in peripheral blood CD34+ cells and CD2+ lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting

1 reference

https://api.crossref.org/works/10.1002%2FIJC.1452

21 January 2018

Identifiers

10.1002/IJC.1452

1 reference

Europe PubMed Central

26 November 2017

1 reference

Europe PubMed Central

26 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43773475&oldid=2103207061"